These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24712867)
21. Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice. Cooke EJ; Zhou JY; Wyseure T; Joshi S; Bhat V; Durden DL; Mosnier LO; von Drygalski A Thromb Haemost; 2018 Jun; 118(6):1036-1047. PubMed ID: 29847841 [TBL] [Abstract][Full Text] [Related]
22. Haemarthrosis and arthropathy do not favour the development of factor VIII inhibitors in severe haemophilia A mice. Peyron I; Dimitrov JD; Delignat S; Gangadharan B; Planchais C; Kaveri SV; Lacroix-Desmazes S Haemophilia; 2015 Jan; 21(1):e94-8. PubMed ID: 25471131 [No Abstract] [Full Text] [Related]
23. Knee arthropathy: when things go wrong. Solimeno L; Luck J; Fondanesche C; McLaughlin P; Narayan P; Sabbour A; Sohail T; Pasta G Haemophilia; 2012 Jul; 18 Suppl 4():105-11. PubMed ID: 22726092 [TBL] [Abstract][Full Text] [Related]
24. The effect of bleeding patterns on the response of haemophilic haemarthroses to different doses of factor VIII. Aronstam A; Wassef M; Hamad Z; McLellan DS Clin Lab Haematol; 1981; 3(2):107-12. PubMed ID: 6788433 [TBL] [Abstract][Full Text] [Related]
25. Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors. Medeiros D; Laufenberg JA; Miller KL; Buchanan GR Haemophilia; 2007 Jan; 13(1):85-9. PubMed ID: 17212730 [TBL] [Abstract][Full Text] [Related]
26. Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond. Forsyth AL; Rivard GÉ; Valentino LA; Zourikian N; Hoffman M; Monahan PE; Van Meegeren ME; Forriol F Haemophilia; 2012 Jul; 18 Suppl 4():112-9. PubMed ID: 22726093 [TBL] [Abstract][Full Text] [Related]
27. [Joint bleeding in haemophiliacs receiving substitution treatment as out-patients (author's transl)]. Barthels M; Gerstel J Dtsch Med Wochenschr; 1975 Jul; 100(29):1523-9. PubMed ID: 1149632 [TBL] [Abstract][Full Text] [Related]
28. Effect of low-dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A. Gamal Andrawes N; Hashem Fayek M; Salah El-Din N; Atef Mostafa R Haemophilia; 2020 Mar; 26(2):325-332. PubMed ID: 31884718 [TBL] [Abstract][Full Text] [Related]
29. Changing patterns of bleeding in patients with severe haemophilia A. Stephensen D; Tait RC; Brodie N; Collins P; Cheal R; Keeling D; Melton K; Dolan G; Haye H; Hayman E; Winter M Haemophilia; 2009 Nov; 15(6):1210-4. PubMed ID: 19659938 [TBL] [Abstract][Full Text] [Related]
30. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice. Ovlisen K; Kristensen AT; Valentino LA; Hakobyan N; Ingerslev J; Tranholm M J Thromb Haemost; 2008 Jun; 6(6):969-75. PubMed ID: 18363814 [TBL] [Abstract][Full Text] [Related]
31. Surgical complications in a hemophilia patient with factor VIII inhibitor and their endovascular management. Sadat U; Naik J; Hayes PD Vasc Endovascular Surg; 2008; 42(2):168-72. PubMed ID: 18421033 [TBL] [Abstract][Full Text] [Related]
32. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis. den Uijl IE; Fischer K Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430 [No Abstract] [Full Text] [Related]
33. Management of joint bleeding in hemophilia. Simpson ML; Valentino LA Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238 [TBL] [Abstract][Full Text] [Related]
34. [Prevention of joint damage in hemophilic children with early prophylaxis]. Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528 [TBL] [Abstract][Full Text] [Related]
35. Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. Manners PJ; Price P; Buurman D; Lewin B; Smith B; Cole CH J Rheumatol; 2015 May; 42(5):885-90. PubMed ID: 25729030 [TBL] [Abstract][Full Text] [Related]
36. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Valentino LA; Hakobyan N; Kazarian T; Jabbar KJ; Jabbar AA Haemophilia; 2004 May; 10(3):280-7. PubMed ID: 15086328 [TBL] [Abstract][Full Text] [Related]
37. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A. Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610 [TBL] [Abstract][Full Text] [Related]
38. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study. Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137 [TBL] [Abstract][Full Text] [Related]
39. The impact of joint bleeding and synovitis on physical ability and joint function in a murine model of haemophilic synovitis. Mejia-Carvajal C; Hakobyan N; Enockson C; Valentino LA Haemophilia; 2008 Jan; 14(1):119-26. PubMed ID: 18184259 [TBL] [Abstract][Full Text] [Related]
40. Orthopaedic management of haemophilia arthropathy of the ankle. Pasta G; Forsyth A; Merchan CR; Mortazavi SM; Silva M; Mulder K; Mancuso E; Perfetto O; Heim M; Caviglia H; Solimeno L Haemophilia; 2008 Jul; 14 Suppl 3():170-6. PubMed ID: 18510538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]